Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2016 Feb 13;95(1):120–130. doi: 10.1016/j.ijrobp.2016.02.022

Table 1.

Human tumor cells of diverse origin recovering from photon or proton radiation harbor similar patterns of immunogenic modulation on the cell surface.

Surface Expression: % Positive cells (MFI)
Gy Viability HLA CEA MUC-1 ICAM-1 Fraction
per cell line
Radiation Modality LNCaP Photon 0 95 92(104) 2 (27) 8 (27) 3 (30)
8 84 92 (425) 15 (181) 8 (70) 6 (53) 4/4
Proton 0 96 99 (123) 2 (21) 9 (32) 3 (38)
8 86 95 (304) 9 (102) 12 (58) 6 (750) 4/4
MDA-MB-231 Photon 0 78 99 (415) 4 (38) 17 (138) 90 (250)
8 65 99 (886) 4 (220) 31 (210) 95 (1110) 4/4
Proton 0 91 99 (390) 3 (63) 4 (13) 69 (129)
8 76 99 (682) 4 (109) 14 (81) 86 (751) 4/4
H1703 Photon 0 92 99 (633) 2 (39) 47 (25) 7 (40)
8 77 99 (930) 2 (190) 25 (119) 25 (119) 3/4
Proton 0 96 99 (409) 2 (31) 21 (32) 4 (34)
8 81 99 (501) 2 (52) 27 (47) 16 (45) 3/4
JHC7 Photon 0 83 98 (536) 5 (239) 11 (120) 57 (235)
8 76 98 (580) 10 (180) 12 (113) 63 (243) 2/4
Proton 0 88 99 (579) 13 (133) 10 (99) 87 (254)
8 81 99 (667) 15 (179) 12 (102) 90 (395) 3/4
28/32 (87.5%)

Human prostate (LNCaP), breast (MDA-MB-231), lung (H1703), and chordoma (JHC7) carcinoma cells were mock-irradiated (0 Gy) or exposed to a single dose of 8 Gy photon or proton radiation. After 96 h, cells were analyzed by flow cytometry. Viability was determined for the entire cell populations by live/dead staining as described in materials and methods. For surface expression of HLA-ABC (MHC-I), CEA, MUC-1, and ICAM-1, analysis was conduced on gated viable cells. Numbers indicate percentage of positive cells. Numbers in parentheses denote mean fluorescence intensity (MFI). Bold type indicates marked upregulation (≥ 10% increase in percent of cells or 50% increase in MFI not observed in isotype control vs. untreated cells). Data shown is representative of experiment repeated 3 times with similar results.